chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This 11 year old female consumer was given human papillomavirus (HPV4) 0.5mL, meningococcal conjugated vaccine (MCV4) 0.5mL, tetanus, diphtheria, and pertussis vaccine (TDAP) 0.5mL, and Inactivated Seasonal Influenza Vaccine (TIV) 0.5mL on 03Nov2010. The patient's relevant medical history includes no previous allergic reaction to HPV4, MCV4, TDAP, or TIV. On 03Nov2010, after receiving the vaccines, the patient was send to the waiting room to be observed before going back to class. A few minutes after receiving vaccines, the patient had a vasovagal reaction 2 minutes after receiving vaccines. The patient was not hurt and she was kept in the clinic until she was feeling better to go back to class. No additional laboratory testing was required.
Pt felt rapid heartbeat and stated her pulse can fluctuate between 150-160 BPM due to cycles of anxiety. Vitals assessed. 148/92 BP, 130 PR, 98% O2 room air. Patient asked to be moved outside. Pt escorted by EMT. patient listened to relaxing music and used breathing techniques. Patient also went to bathroom to splash cold water on her face. Pt refused medication and transportation. Pt monitored and reassessed at 1215. 142/80 bpm, 125 PR, 99% O2. Pt stated feeling more relaxed and stated she wanted to leave .  Pt left facility with steady gait at 1218 with family.
I have been having shortness of breath and heart palpitations. I have a tri level home and just going up and down the steps have caused a shortness of breath. Heart palpitations began during a meeting. I work from home. It happened again while I was exercising. I recorded it using my Apple watch which reflected that it was not a normal rhythm. Over the course of a week, I had a few other episodes. I still get shortness of breath but it is not as bad. The doctor did an x-ray to ensure I did not have an enlarged heart as I did have COVID also in December. I had a stress test. I had to do a nuclear stress test called lexa-scan which were both normal. Since I have not have not been having the episodes, I have not followed.
This spontaneous report was received from a pharmacist refers to an unspecified patients of unknown age and gender. No pertinent medical history was reported. On 05-NOV-2015, the patient was vaccinated with first dose of improperly stored VARIVAX (Merck) (dose, route and lot# were not reported) which was stored in a refrigerator for less than 72 hours. After pharmacist realized that improperly stored VARIVAX (Merck) dose was administered to patient, pharmacist considered the first dose as invalid and on 14-NOV-2015 administered another VARIVAX (Merck) dose. No adverse effects were reported. No Product Quality Complaint (PQC) was involved. Additional information has been requested.
Received vaccine on 1/8/21. Arm was not sore at first, but has been warm to touch and hard since early after vaccine. Also noted swollen lymph nodes on right side - which is same side she received vaccine.  Could move arm without problem. Last night during bath on 1/13/21, could feel more tender and noted it was red and swollen and warm to touch - like it had a fever..
Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Joint pain). At the time of the report, ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment medication was not provided.   Reporter did not allow further contact
Severe flu-like symptoms: muscle or body aches as well as extreme fatigue (tiredness) that started approximately 5 hours after receiving the vaccination and lasted for 2.5 days afterwards.
Exactly 3 hours after receiving shot, he became inconsolable, had a fever, diarrhea (his rear was like a faucet), he didn't nurse for 9 hours and normally he cluster feeds and nurses every hour in the evening, he was extremely fussy, and seemed to have a tender leg.  This lasted for about 24 hours.
Cellulitis to right thigh. Antibiotics prescribed sulfamethoxazole - trimethoprim 200-40 mg/5 ml 8 ml BID x 10 days.
pt recv vax 7JUN95 & 12JUN95 severe cervical h/a-devel hives on lower legs & hip-arm-hardened area -2" x 1" & bruised appearance
pt recv ax 10APR96 & was exposed to varicella zoster on 11APR97;22APR97 pt devel approx 30 blisters;pt recovered from sz by 26APR97;
Seizure 2 days after immunizations. Hospitalized 24 hrs. EEG & CAT scan read normal, has been sent to neurologist for evaluation. Temp at injection 100.8.
have experienced a side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (have experienced a side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in January 2021.    In June 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (have experienced a side effect). At the time of the report, VACCINATION COMPLICATION (have experienced a side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs were reported. No treatment medications were reported.
information about a 12 year-old patient that received Infanrix instead of Boostrix; information about a 12 year-old patient that received Infanrix instead of Boostrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old male patient who received DTPa (Infanrix) (batch number 9HP9Z, expiry date 21-APR-2024) for prophylaxis.   On 25-AUG-2023, the patient received Infanrix. On 25-AUG-2023, an unknown time after receiving Infanrix, the patient experienced wrong vaccine administered (Verbatim: information about a 12 year-old patient that received Infanrix instead of Boostrix) and inappropriate age at vaccine administration (Verbatim: information about a 12 year-old patient that received Infanrix instead of Boostrix).  The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 29-AUG-2023 The reported stated 12 year old patient received Infanrix instead of Boostrix which led to wrong vaccine administration and Inappropriate age at vaccine administration. The Healthcare profession wanted to know how to proceed with the patient. The reporter consented to follow up.
Information was received from an attorney regarding a case in litigation concerning a female patient of unknown age. Medical history, concurrent conditions and concomitant medications were not provided. In or around 03-OCT-2014, the patient was inoculated at a hospital with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. In 2016, the patient was treated for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long term prevention of shingles. The patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
ANXIETY, DIZZINESS TX: HYDRATE, SNACK/REPOSITION/COLD COMPRESS SX: RESOLVED NO TRANSPORT
Headache-30 minutes after injection , constant for over two full months, would go to bed with it and wake up with it, pain lower back of the head and behind left eye. Vision- within 5 days or so of the vaccine vision was as if I was looking through a glass with static, similar to the static you see when your TV looses signal Smell of smoke- within a wk from the vaccine I began to feel as if someone was smoking right by my side. At first I thought it was my neighbor but the smell was too strong and bothersome to be next door. Rash- around 8 days after the vaccine a round rash around the site of the vaccine, about 4 in in diameter, red, raised and warm to touch, since then rashes all over the body at the beginning raised, itchy, red, warm after three months rash appeared sometimes flat like red strike rather then round raised. Chronic fatigue- after vaccine but became worse within the month until it got to a point in which I could barely function just had enough energy to go to work and laid down when I got back. I was afraid I was going to lose my job because I wasn?t functioning not even a 50%of my normal. Vertigo- started experiencing vertigo feeling like everything around me was suddenly spinning  hours after vaccination  Difficulty communicating trying to say one thing and coming out differently
States has area approx 1 inch at site which feels numb sometimes. Site was left arm.
about 10 minutes after vaccination when ask how she was doing she reported some itching in throat, but no swelling or shortness of breath.  We administered 1 dose of Benadryl 25mg orally.  She stayed in store for another 30 minutes with no further increase in symptoms.   We checked on her via phone on the 27th and 28th and she reported she was felling just fine.
COVID19+: Yes-positive rapid test last month.; COVID19+: Yes-positive rapid test last month.; 29Jun2021  as dose 2/ 10May2021 as dose 1; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MDCA22-00635.  A male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 29Jun2021 (Batch/Lot number: unknown) as dose 2, single and intramuscular, administered in arm left, administration date 10May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "MS" (unspecified if ongoing), notes: Infusion every 6 months for MS. Concomitant medication(s) included: OCREVUS taken for multiple sclerosis. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Feb2022, outcome "recovered" and all described as "COVID19+: Yes-positive rapid test last month."; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 29Jun2021, outcome "unknown", described as "29Jun2021  as dose 2/ 10May2021 as dose 1". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Feb2022) positive.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Site: Pain at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Severe, Additional Details: Patient reported that after shot his left thigh and stomach broke out in a red, itchy rash. He took some oral benadryl and applied hydrocortisone cream twice daily in order to make the rash go away. Rash lasted about 7 days
Patient experienced extreme muscle soreness/weakness and went to ER the evening of vaccination. She was told by physician to take Ibuprofen and rest. Patient also had redness and swelling at site of injection. She received 2 injections in right arm because surgery on left side.
alteration in taste/salty taste; metallic taste in the tip of the tongue that comes and goes; had soreness to her unknown arm at injection site; This is a spontaneous report from a contactable consumer (patient).   A female patient of an unspecified age received bnt162b2 ((PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6205 and Batch/Lot Number: EN6207), via an unspecified route of administration in Arm on 05Apr2021 as 2nd dose, single dose for COVID-19 immunisation. Medical history included, ongoing hypothyroidism stated that she has had it since she was a child. Concomitant medication included levothyroxine (LEVOTHYROXINE) 200mcg by mouth every day taken for hypothyroidism from an unspecified start date (started when she was 8 years old) and ongoing, liothyronine (LIOTHYRONINE) 5mcg by mouth every day taken for hypothyroidism from an unspecified start date and ongoing. The patient previously received bnt162b2 (BNT162B2) in 2021 with soreness to unknown arm at injection site. The patient experienced alteration in taste/salty taste on an unspecified date, metallic taste in the tip of the tongue that comes and goes on 17Apr2021, and had soreness to her unknown arm at injection site 05Apr2021. The patient reported as she got the second dose of the Pfizer covid vaccine on April 5th and since then she has alteration in taste, a metallic taste in the tip of the tongue that comes and goes. The patient was not sure whether it is vaccine related or this could be a exposition to the covid 19 virus. In response it was told that alteration in taste has not been reported as a side effect and was suggested to consult her physician or HCP to get some recommendations. The patient stated that she took the Pfizer vaccine first and second dose and had no symptoms prior to it. Stated that after approximately two weeks that she had a metallic, salty taste a lot of times not all of times and she was not eating that the taste was on the tip of her tongue. She was not sure if it is from the vaccine but she is reporting it due to the timing. She had soreness to her unknown arm at injection site. She went to the Center and there were doctor's. The soreness to the injection site lasted the first day and was gone. The second dose was given closer to four weeks instead of three weeks because she could not go on that date. The metallic taste started on 17Apr2021 or 18Apr2021. Her main concern was about a treatment recommendation about the case. Treatment received for the events were none. Outcome of the event taste alteration, metallic taste was not recovered and recovered for soreness to injection site.  Information on Lot/Batch number was available. Additional information has been requested.
I had mild chest and head congestion when I woke up on Sunday morning, 05/15/2022. So I took an at-home COVID-19 test, and it came back positive. I emailed my physician and informed her that I tested positive; she informed me to stay home, stay hydrated, and treat it like a regular cold. My symptoms are pretty mild currently, I'm supposing thanks to the recent booster I just received.
4/4/03: Mom states vaccines given with minor cold symptom (runny nose, minor cough). Denies fever. 4/7/03: Noticed more cough with higher severity. 4/8/03: Concerned about symptoms. Child taken to ER with difficulty breathing. CXR done with diagnosis pneumonia.
Spent several days in bed sick afterwards; Arm hurt like hell for a week; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain in extremity (1st dose received on unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm and sickness. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain in arm and sickness were recovered/resolved.   It was unknown if the reporter considered the pain in arm and sickness to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The age group was not reported but it was captured as an adult as per vaccine indication. The patient receive 2nd dose of Shingrix and arm hurt really bad and spent several days in bed sick afterwards. The patient stated that it was better than getting shingles. The follow up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR104374:1st dose,same reporter,same AE
Pt developed fever the evening after receiving Tdap vaccine. I could not determine source - but I did Rx with steroid and Abx. He resolved in 24 hrs.
1/21  Significant itching at injection site.  Refrained from touching. By evening progressed to small area of redness and swelling. 1/22  Much larger area, rosy red, swelling and felt hot.  Applied ice.  Area affected continued to spread. 1/25 Presently extends from shoulder to arm pit, but not under arm.  About size of  very large orange.  Tender, but not painful.  Very itchy, still red, hot feeling, and puffy. Hopeful it is safe to receive 2nd dose around 2/14/2021
This spontaneous report as received from a medical assistant refers to a 4 year old patient of unknown gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On 06-SEP-2016 , the patient was vaccinated with a dose of improperly stored PROQUAD lot # M015695 with expiration date 26-SEP-2017, therapy type HSA. It was reported that the vaccine was improperly stored at -3.5 Celsius for 1 hour and 6 minutes. There was no previous temperature excursion. Data logger was involved. No symptoms were reported. This is one of several reports received from the same reporter. Additional information is not expected as all relevant information has been received. Sender's Comments: US-009507513-1610USA011245.
Pt developed a rash; onset 3 days ago. Also had malaise and headache. Seen on 9/23/01 and had 5 vesicles and 20 spots.
This case was reported by a healthcare professional and described the occurrence of group b streptococcus in an infant male subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). On unspecified dates (either within three months prior to or during pregnancy) the subject's mother received prenatal vitamins and calcium. On 18 November 2008 at 10:15 the subject received unspecified dose of BOOSTRIX (.5 ml, transplacentary). The subject was born via spontaneous vaginal delivery at 38 weeks gestation. Weight was 3.28 kg. Apgar scores were 8 at one minute and 9 at five minutes. He was reported to be a healthy infant. At an unspecified time after vaccination with BOOSTRIX, the subject experienced positive group b streptococcus and "meconium". Fetal/neonatal status was reported to be normal; however, chorioanmionitis (see case A0758632A for mother case), positive group b streptococcus and "meconium" were also reported. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events was unspecified.
Rec. TWINRIX (Hep A/B) in Right deltoid, Typhoid Vi (L) deltoid on 8/6/2013. Several hrs. later developed - SOB - ER - BENADRYL, discharged developed rash later in day - ER and admitted as of 8/9/2013 - still hospitalized. NKDA.
This is a spontaneous case report sent to a private physician that refers to a male aged 8 years. He received FluMist on 1/17/05 at 1:00 in the afternoon. The patient's concomitant medication included cefdinir. On 1/21/05, the patient presented in the reporters office complaining of left ear pain. He received ciprofloxacin and dexamethasone for treatment of the ear pain. On 1/24/05, the patient developed fever, vomiting, pain in his right leg, right foot, pain in his wrist, and elbow. He complained that he could not walk and could only move his toes. On 1/25/05, he presented in the reporter's office and required hospitalization for group A streptococcal bacteremia, osteomyelitis, and arthritis. He was placed on the general floor and was discharged on 2/11/05. As of 2/22/05, the patient is at home on IV antibiotics, out of school, and using a walker and bed pan. He is recovering slowly. The reporter stated the events were not related to FluMist. 04 Aug 05- Several attemps made to obtain patient's recovery status but unable to. Letter requesting this information was sent to the reporter/ physician.
About 19 hours after receiving the Pfizer Covid-19 vaccine, I got a fever of 101 degrees.  My left arm felt very heavy.
Fever 3MAY93 105, diarrhea, fatigue, blotches on skin, itchy; loss of appetite; sore throat; was given antibiotics, 'Demitab', Tylenol, 'Perialite', & suppository;
EMERGENCY SURGERY TO REMOVE APPENDIX; This spontaneous report received from a parent via a company representative concerned a 35 year old male of an unspecified race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of administration was not reported, batch number: unknown and expiry: unknown) dose, start therapy date were not reported, 01 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch numbers. No concomitant medications were reported.  On 17-DEC-2021, a post was shared by a parent stated "Not getting booster, however I chose to get my shots because of my age and weight, no one forced me. That's immoral Wish I had not gotten the jabs. My 35 year old military son got jab, 38 hours later was in emergency surgery to remove appendix, Side effect ". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of emergency surgery to remove appendix was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211240198-COVID-19 VACCINE AD26.COV2.S- Emergency surgery to remove appendix . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Pt recvd 2-1cc injects of Recombivax 3DEC90 & 2JAN91; 6JUN91 recvd Engerix-B; pt "did not develop immunity";
pt recvd 2 doses of vax 2nd dose was administered 10AUG92; 20AUG92 pt exp dizziness & muscle soreness in arm;
Tingling after shot to left side of face and neck. Onset of a headache within 5 minutes of receiving the vaccination. Developed puffiness to left cheek.